rs1554402092
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 13 ACMG points: 13P and 0B. PM2PP2PP3_ModeratePP5_Very_Strong
The ENST00000395749.7(CAMK2B):c.328G>A(p.Glu110Lys) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Genomes: not found (cov: 30)
Consequence
CAMK2B
ENST00000395749.7 missense
ENST00000395749.7 missense
Scores
8
9
2
Clinical Significance
Conservation
PhyloP100: 7.08
Genes affected
CAMK2B (HGNC:1461): (calcium/calmodulin dependent protein kinase II beta) The product of this gene belongs to the serine/threonine protein kinase family and to the Ca(2+)/calmodulin-dependent protein kinase subfamily. Calcium signaling is crucial for several aspects of plasticity at glutamatergic synapses. In mammalian cells, the enzyme is composed of four different chains: alpha, beta, gamma, and delta. The product of this gene is a beta chain. It is possible that distinct isoforms of this chain have different cellular localizations and interact differently with calmodulin. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 13 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), CAMK2B. . Gene score misZ 4.0707 (greater than the threshold 3.09). Trascript score misZ 3.3558 (greater than threshold 3.09). GenCC has associacion of gene with intellectual disability, autosomal dominant 54, intellectual disability, autosomal dominant 40, autosomal dominant non-syndromic intellectual disability.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.932
PP5
Variant 7-44254555-C-T is Pathogenic according to our data. Variant chr7-44254555-C-T is described in ClinVar as [Pathogenic]. Clinvar id is 430921.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-44254555-C-T is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CAMK2B | NM_001220.5 | c.328G>A | p.Glu110Lys | missense_variant | 5/24 | ENST00000395749.7 | NP_001211.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CAMK2B | ENST00000395749.7 | c.328G>A | p.Glu110Lys | missense_variant | 5/24 | 1 | NM_001220.5 | ENSP00000379098 |
Frequencies
GnomAD3 genomes Cov.: 30
GnomAD3 genomes
Cov.:
30
GnomAD4 exome Cov.: 29
GnomAD4 exome
Cov.:
29
GnomAD4 genome Cov.: 30
GnomAD4 genome
Cov.:
30
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Intellectual disability, autosomal dominant 54 Pathogenic:2
Pathogenic, no assertion criteria provided | literature only | OMIM | Apr 28, 2022 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | 3billion | Jan 03, 2022 | The variant has been previously reported as de novo in a similarly affected individual (PMID: 29100089, , PS2_S). It is not observed in the gnomAD v2.1.1 dataset (PM2_M). The variant is located in a well-established functional domain or exonic hotspot, where pathogenic variants have frequently reported (PM1_M). In silico tool predictions suggest damaging effect of the variant on gene or gene product (3CNET: 0.996, PP3_P). A missense variant is a common mechanism associated with Mental retardation (PP2_P). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline. - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Sep 08, 2022 | Published functional studies demonstrate a damaging effect as in vitro assay showed E110K had reduced expression along with reduced pT286/287 phosphorylation (Kury et al., 2017); Not observed in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 29100089, 35813072, 33774142, 35620293) - |
Intellectual disability Pathogenic:1
Pathogenic, no assertion criteria provided | research | Laboratory of Molecular Genetics (Pr. Bezieau's lab), CHU de Nantes | Jul 03, 2017 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Uncertain
.;.;T;.;.;.;.;.;.;.;T;T;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Pathogenic
.;.;D;D;D;D;D;D;D;D;D;D;D
M_CAP
Uncertain
D
MetaRNN
Pathogenic
D;D;D;D;D;D;D;D;D;D;D;D;D
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;M;M;M;M;M;M;M;M;M;.;.;.
MutationTaster
Benign
D;D;D;D;D;D;D;D;D;D;D
PrimateAI
Pathogenic
D
PROVEAN
Uncertain
D;D;D;D;D;D;D;D;D;D;D;D;D
REVEL
Uncertain
Sift
Uncertain
D;D;D;D;D;D;D;D;D;D;D;D;D
Sift4G
Pathogenic
D;D;D;D;D;D;D;D;D;D;.;.;.
Polyphen
D;D;D;D;P;D;D;P;P;D;.;.;.
Vest4
MutPred
Gain of ubiquitination at E110 (P = 0.0162);Gain of ubiquitination at E110 (P = 0.0162);Gain of ubiquitination at E110 (P = 0.0162);Gain of ubiquitination at E110 (P = 0.0162);Gain of ubiquitination at E110 (P = 0.0162);Gain of ubiquitination at E110 (P = 0.0162);Gain of ubiquitination at E110 (P = 0.0162);Gain of ubiquitination at E110 (P = 0.0162);Gain of ubiquitination at E110 (P = 0.0162);Gain of ubiquitination at E110 (P = 0.0162);.;Gain of ubiquitination at E110 (P = 0.0162);Gain of ubiquitination at E110 (P = 0.0162);
MVP
MPC
3.0
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at